TRBC1/TRBC2 Immunophenotyping Provides Added Value During the Diagnostic Workup of T-Cell Lymphoma.

Saved in:
Bibliographic Details
Title: TRBC1/TRBC2 Immunophenotyping Provides Added Value During the Diagnostic Workup of T-Cell Lymphoma.
Authors: Taylor J; Department of Clinical Haematology Royal London Hospital Barts Health NHS Trust London UK.; Precision Health University Research Institute Queen Mary University of London London UK., Lakum T; Specialist Integrated Haematological Malignancy Diagnostic Service Royal London Hospital Barts Health NHS Trust London UK., Bevan S; Specialist Integrated Haematological Malignancy Diagnostic Service Royal London Hospital Barts Health NHS Trust London UK.; National Acute Lymphoblastic Leukaemia MRD Service Barts Health NHS Trust London UK., Freeman T; Department of Clinical Haematology Royal London Hospital Barts Health NHS Trust London UK., Boot J; Department of Haemato-Oncology St Bartholomew's Hospital Barts Health NHS Trust London UK.; Barts Cancer Institute Queen Mary University of London London UK., Bigogno CM; Department of Clinical Haematology Royal London Hospital Barts Health NHS Trust London UK., Raine J; Department of Cellular Pathology Royal London Hospital Barts Health NHS Trust London UK., Hookway E; Department of Cellular Pathology Royal London Hospital Barts Health NHS Trust London UK., Medani H; Department of Cellular Pathology Royal London Hospital Barts Health NHS Trust London UK., Calaminici M; Department of Cellular Pathology Royal London Hospital Barts Health NHS Trust London UK., Okosun J; Department of Haemato-Oncology St Bartholomew's Hospital Barts Health NHS Trust London UK.; Barts Cancer Institute Queen Mary University of London London UK., Grantham M; Specialist Integrated Haematological Malignancy Diagnostic Service Royal London Hospital Barts Health NHS Trust London UK.; National Acute Lymphoblastic Leukaemia MRD Service Barts Health NHS Trust London UK., Araf S; Department of Clinical Haematology Royal London Hospital Barts Health NHS Trust London UK., Smith M; Department of Clinical Haematology Royal London Hospital Barts Health NHS Trust London UK., Butler T; Department of Clinical Haematology Royal London Hospital Barts Health NHS Trust London UK., Farren T; Specialist Integrated Haematological Malignancy Diagnostic Service Royal London Hospital Barts Health NHS Trust London UK.; Barts Cancer Institute Queen Mary University of London London UK.
Source: EJHaem [EJHaem] 2025 Dec 22; Vol. 6 (6), pp. e70192. Date of Electronic Publication: 2025 Dec 22 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first